Emergence of ISAba1 harboring carbapenem-resistant Acinetobacter baumannii isolates in Pakistan

Future Microbiology

Volumn 12, Issue 14, 2017, Pages 1261-1269

  Khurshid, Mohsin ^a   Rasool, Muhammad Hidayat ^a   Ashfaq, Usman Ali ^a   Aslam, Bilal ^a   Waseem, Muhammad ^a  

^a GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

Author keywords

Acinetobacter baumannii; insertion sequence; ISAba1; oxacillinases

Indexed keywords

BACTERIAL PROTEIN; CARBAPENEM; ISABA1 PROTEIN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; OXACILLINASE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLONE; CONTROLLED STUDY; GENE INSERTION; GENE OVEREXPRESSION; GENETIC VARIABILITY; MULTIDRUG RESISTANCE; NONHUMAN; PAKISTAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TERTIARY CARE CENTER; ACINETOBACTER INFECTION; BETA-LACTAM RESISTANCE; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; MICROBIOLOGY; TRANSPOSON;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTIGENS, BACTERIAL; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; DNA TRANSPOSABLE ELEMENTS; HUMANS; PAKISTAN; TERTIARY CARE CENTERS;

EID: 85034104674     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb-2017-0080     Document Type: Article

References (42)

1. Sohail M, Rashid A, Aslam B et al. Antimicrobial susceptibility of Acinetobacter clinical isolates and emerging antibiogram trends for nosocomial infection management. Rev. Soc. Bras. Med. Trop. 49(3), 300-304 (2016).
2. Viehman JA, Nguyen MH, Doi Y. Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections. Drugs 74(12), 1315-1333 (2014).
3. Zhao SY, JiangDY, Xu PC et al. An investigation of drug-resistant Acinetobacter baumannii infections in a comprehensive hospital of East China. Ann. Clin. Microbiol. Antimicrob. 14, 7 (2015).
4. Novovic K, Mihajlovic S, Vasiljevic Z, Filipic B, Begovic J, Jovcic B. Carbapenem-resistant Acinetobacter baumannii from Serbia: revision of CarO classification. PLoS ONE 10(3), e0122793 (2015).
5. Joshi PR, Acharya M, Kakshapati T, Leungtongkam U, Thummeepak R, Sitthisak S. Co-existence of blaOXA-23 and blaNDM-1 genes of Acinetobacter baumannii isolated from Nepal: antimicrobial resistance and clinical significance. Antimicrob. Resist. Infect. Control. 6, 21 (2017).
6. Hasan B, Perveen K, Olsen B, Zahra R. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan. J. Med. Microbiol. 63(Pt. 1), 50-55 (2014).
7. Walsh TR. Emerging carbapenemases: a global perspective. Int. J. Antimicrob. Agents 36(Suppl. 3), S8-S14 (2010).
8. Lee Y, Kim CK, Lee H, Jeong SH, Yong D, Lee K. A novel insertion sequence, ISAba10, inserted into ISAba1 adjacent to the bla(OXA-23) gene and disrupting the outer membrane protein gene carO in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55(1), 361-363 (2011).
9. Martinez P, Mattar S. Imipenem-resistant Acinetobacter baumannii carrying the ISAba1-blaOXA-23, 51 and ISAba1-bla ADC-7 genes in Monteria, Colombia. Braz. J. Microbiol. 43(4), 1274-1280 (2012).
10. Mugnier PD, Poirel L, Nordmann P. Functional analysis of insertion sequence ISAba1, responsible for genomic plasticity of Acinetobacter baumannii. J. Bacteriol. 191(7), 2414-2418 (2009).
11. Teixeira AB, Martins AF, Barin J, Hermes DM, Pitt CP, Barth AL. First report of carbapenem-resistant Acinetobacter nosocomialis isolates harboring ISAba1-blaOXA-23 genes in Latin America. J. Clin. Microbiol. 51(8), 2739-2741 (2013).
12. Bahador A, Raoofian R, Pourakbari B, Taheri M, Hashemizadeh Z, Hashemi FB. Genotypic and antimicrobial susceptibility of carbapenem-resistant Acinetobacter baumannii: analysis of is Aba elements and bla OXA-23-like genes including a new variant. Front. Microbiol. 6, 1249 (2015).
13. Chen TL, Siu LK, Wu RC et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin. Microbiol. Infect. 13(8), 801-806 (2007).
14. Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J. Clin. Microbiol. 39(1), 183-190 (2001).
15. Patel JB, Cockerill FR 3rd, Alder J et al. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. M100-S24. Clinical and Laboratory Standards Institute (CLSI), Wayne, PA, USA (2014).
16. Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18(3), 268-281 (2012).
17. Xiao-Min X, You-Fen F, Wei-Yun F, Zu-Huang M, Xing-Bei W. Antibiotic resistance determinants of a group of multidrug-resistant Acinetobacter baumannii in China. J. Antibiot. 67(6), 439-444 (2014).
18. Woodford N, Ellington MJ, Coelho JM et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27(4), 351-353 (2006).
19. Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob. Agents Chemother. 50(10), 3396-3406 (2006).
20. Ellington MJ, Kistler J, Livermore DM, Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J. Antimicrob. Chemother. 59(2), 321-322 (2007).
21. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70(1), 119-123 (2011).
22. Hornsey M, Phee L, Wareham DW. A novel variant, NDM-5, of the New Delhi metallo-beta-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob. Agents Chemother. 55(12), 5952-5954 (2011).
23. Du J, Li P, Liu H, Lu D, Liang H, Dou Y. Phenotypic and molecular characterization of multidrug resistant Klebsiella pneumoniae isolated from a university teaching hospital, China. PLoS ONE 9(4), e95181 (2014).
24. Turton JF, Ward ME, Woodford N et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258(1), 72-77 (2006).
25. Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 19(24), 6823-6831 (1991).
26. Evans BA, Hamouda A, Abbasi SA, Khan FA, Amyes SG. High prevalence of unrelated multidrug-resistant Acinetobacter baumannii isolates in Pakistani military hospitals. Int. J. Antimicrob. Agents 37(6), 580-581 (2011).
27. Irfan S, Turton JF, Mehraj J et al. Molecular and epidemiological characterisation of clinical isolates of carbapenem-resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan. J. Hosp. Infect. 78(2), 143-148 (2011).
28. Aly M, Tayeb HT, Al Johani SM et al. Genetic diversity of OXA-51-like genes among multidrug-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia. Eur. J. Clin. Microbiol. Infect. Dis. 33(7), 1223-1228 (2014).
29. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44(8), 2974-2976 (2006).
30. Farsiani H, Mosavat A, Soleimanpour S et al. Limited genetic diversity and extensive antimicrobial resistance in clinical isolates of Acinetobacter baumannii in north-east Iran. J. Med. Microbiol. 64(7), 767-773 (2015).
31. Cicek AC, Saral A, Iraz M et al. OXA-and GES-type beta-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin. Microbiol. Infect. 20(5), 410-415 (2014).
32. Pagano M, Martins AF, Machado AB, Barin J, Barth AL. Carbapenem-susceptible Acinetobacter baumannii carrying the ISAba1 upstream blaOXA-51-like gene in Porto Alegre, southern Brazil. Epidemiol. Infect. 141(2), 330-333 (2013).
33. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48(1), 1-14 (2004).
34. Habeeb MA, Haque A, Iversen A, Giske CG. Occurrence of virulence genes, 16S rRNA methylases, and plasmid-mediated quinolone resistance genes in CTX-M-producing Escherichia coli from Pakistan. Eur. J. Clin. Microbiol. Infect. Dis. 33(3), 399-409 (2014).
35. Perry JD, Naqvi SH, Mirza IA et al. Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J. Antimicrob. Chemother. 66(10), 2288-2294 (2011).
36. Walsh TR, Toleman MA. The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response. J. Antimicrob. Chemother. 67(1), 1-3 (2012).
37. Rolain JM, Parola P, Cornaglia G. New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia? Clin. Microbiol. Infect. 16(12), 1699-1701 (2010).
38. Boulanger A, Naas T, Fortineau N, Figueiredo S, Nordmann P. NDM-1-producing Acinetobacter baumannii from Algeria. Antimicrob. Agents Chemother. 56(4), 2214-2215 (2012).
39. Jones LS, Toleman MA, Weeks JL, Howe RA, Walsh TR, Kumarasamy KK. Plasmid carriage of bla NDM-1 in clinical Acinetobacter baumannii isolates from India. Antimicrob. Agents Chemother. 58(7), 4211-4213 (2014).
40. Pritsch M, Zeynudin A, Messerer M et al. First report on bla NDM-1-producing Acinetobacter baumannii in three clinical isolates from Ethiopia. BMC Infect. Dis. 17(1), 180 (2017).
41. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10(9), 597-602 (2010).
42. Snelling AM, Gerner-Smidt P, Hawkey PM et al. Validation of use of whole-cell repetitive extragenic palindromic sequence-based PCR (REP-PCR) for typing strains belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex and application of the method to the investigation of a hospital outbreak. J. Clin. Microbiol. 34(5), 1193-1202 (1996).